Encision Inc. (ECIA) Stock

About Encision Inc.

Encision Inc. (ECIA), established in 1991 and headquartered in Boulder, Colorado, operates as a medical device firm specializing in the development, manufacturing, and commercialization of proprietary surgical instruments for the U.S. market. The company's core offering revolves around its patented Active Electrode Monitoring (AEM) technology, featured in both surgical instruments and dedicated monitors. This innovative system significantly enhances patient safety and optimizes outcomes during laparoscopic surgical procedures. Encision's AEM instrument portfolio encompasses a diverse array of endo-mechanical tools, such as scissors, graspers, and dissectors, alongside specialized fixed-tip and suction-irrigation electrodes. Beyond these, the company supplies specialized handles designed for complex laparoscopic operations, characterized by their robust shafts and ergonomic designs. They also provide the AEM EndoShield 2 burn protection systems. Complementing these instruments, Encision markets its AEM monitor product line, essential for use in conjunction with its AEM instruments. Distribution of Encision's products occurs through a hybrid sales model, leveraging both direct company representatives and an established network of independent sales agents.

Encision Inc. is headquartered in US.

Encision Inc. (ECIA) stock trades at $0.04 with a market capitalization of $435755. The stock is valued at a price-to-earnings (P/E) ratio of -1.40, price-to-book of 0.42, price-to-sales of 0.07. Over the past 52 weeks the stock has ranged between $0.00 and $0.40, and currently trades 90.0% below its 52-week high.

On profitability, Encision Inc. generates a return on equity (ROE) of -20.14%, return on capital employed of -11.99%, an operating margin of -4.52%, a net profit margin of -5.60%.

Official website: www.encision.com